Therefore, we demonstrate that the use of ABPM along with the sFlt-1/PlGF ratio in women with GDM and obesity may be useful tools to identify those with an increased risk of developing HDP. The gene discussed is PGF; the disease is obesity due to melanocortin 4 receptor deficiency.